121 related articles for article (PubMed ID: 8750508)
1. A bleomycin/ifosfamide/cisplatin regimen exhibits poor activity against persistent or recurrent squamous gynecologic cancers.
Behbakht K; Massad LS; Yordan EL; Lincoln SH; Eriksson JA; Winkelman L; DeGeest K; Kirschner C; Wilbanks GD
Eur J Gynaecol Oncol; 1996; 17(1):7-12. PubMed ID: 8750508
[TBL] [Abstract][Full Text] [Related]
2. Paclitaxel, ifosfamide and cisplatin (TIP) chemotherapy for recurrent or persistent squamous-cell cervical cancer.
Zanetta G; Fei F; Parma G; Balestrino M; Lissoni A; Gabriele A; Mangioni C
Ann Oncol; 1999 Oct; 10(10):1171-4. PubMed ID: 10586332
[TBL] [Abstract][Full Text] [Related]
3. Phase II study of paclitaxel, ifosfamide, and carboplatin in patients with recurrent or metastatic head and neck squamous cell carcinoma.
Shin DM; Khuri FR; Glisson BS; Ginsberg L; Papadimitrakopoulou VM; Clayman G; Lee JJ; Ang KK; Lippman SM; Hong WK
Cancer; 2001 Apr; 91(7):1316-23. PubMed ID: 11283932
[TBL] [Abstract][Full Text] [Related]
4. Experience with bleomycin, ifosfamide, and cisplatin in primary and recurrent cervical cancer.
Buxton EJ
Semin Oncol; 1992 Apr; 19(2 Suppl 5):9-17; discussion 17-8. PubMed ID: 1384148
[TBL] [Abstract][Full Text] [Related]
5. Chemotherapy with paclitaxel, ifosfamide, and cisplatin for the treatment of squamous cell cervical cancer: the experience of Monza.
Zanetta G; Fei F; Mangioni C
Semin Oncol; 2000 Feb; 27(1 Suppl 1):23-7. PubMed ID: 10697040
[TBL] [Abstract][Full Text] [Related]
6. Chemotherapy with mitomycin c, ifosfamide, and cisplatin for recurrent or persistent cervical cancer.
Serkies K; Jassem J; Dziadziuszko R
Int J Gynecol Cancer; 2006; 16(3):1152-6. PubMed ID: 16803499
[TBL] [Abstract][Full Text] [Related]
7. Randomized trial of cisplatin and ifosfamide with or without bleomycin in squamous carcinoma of the cervix: a gynecologic oncology group study.
Bloss JD; Blessing JA; Behrens BC; Mannel RS; Rader JS; Sood AK; Markman M; Benda J
J Clin Oncol; 2002 Apr; 20(7):1832-7. PubMed ID: 11919241
[TBL] [Abstract][Full Text] [Related]
8. Response to Combination Chemotherapy With Paclitaxel/Ifosfamide/Platinum Versus Paclitaxel/Platinum for Patients With Metastatic, Recurrent, or Persistent Carcinoma of the Uterine Cervix: A Retrospective Analysis.
Choi HJ; Paik ES; Choi CH; Kim TJ; Lee YY; Lee JW; Bae DS; Kim BG
Int J Gynecol Cancer; 2018 Sep; 28(7):1333-1341. PubMed ID: 30045137
[TBL] [Abstract][Full Text] [Related]
9. Bleomycin-ifosfamide-cis-platinum (BIP) in pelvic recurrence of previously irradiated cervical carcinoma: a second look.
Ramm K; Vergote IB; Kaern J; Tropé CG
Gynecol Oncol; 1992 Aug; 46(2):203-7. PubMed ID: 1379961
[TBL] [Abstract][Full Text] [Related]
10. Single agent versus combination chemotherapy in recurrent cervical cancer.
Kumar L; Pokharel YH; Kumar S; Singh R; Rath GK; Kochupillai V
J Obstet Gynaecol Res; 1998 Dec; 24(6):401-9. PubMed ID: 10063235
[TBL] [Abstract][Full Text] [Related]
11. The addition of bleomycin and dose-escalated ifosfamide to the combination of cisplatin plus ifosfamide does not improve survival in advanced or recurrent cervical carcinoma.
Hempling RE; Eltabbakh GH; Piver MS; Recio FO; O'Neill CP
Am J Clin Oncol; 1997 Jun; 20(3):315-8. PubMed ID: 9167762
[TBL] [Abstract][Full Text] [Related]
12. A phase I study of ifosfamide, paclitaxel, and carboplatin in advanced and recurrent cervical cancer.
Downs LS; Judson PL; Argenta PA; Carson LF; Boente MP
Gynecol Oncol; 2004 Nov; 95(2):347-51. PubMed ID: 15491756
[TBL] [Abstract][Full Text] [Related]
13. Phase II trial of paclitaxel, ifosfamide, and cisplatin in patients with recurrent head and neck squamous cell carcinoma.
Shin DM; Glisson BS; Khuri FR; Ginsberg L; Papadimitrakopoulou V; Lee JJ; Lawhorn K; Gillenwater AM; Ang KK; Clayman GL; Callender DL; Hong WK; Lippman SM
J Clin Oncol; 1998 Apr; 16(4):1325-30. PubMed ID: 9552033
[TBL] [Abstract][Full Text] [Related]
14. Bleomycin, cisplatinum and ifosfamide infusion chemotherapy in advanced/recurrent cancer of cervix.
Singhal RM; Jindel R; Gupta AK
Indian J Cancer; 1993 Dec; 30(4):158-63. PubMed ID: 7515843
[TBL] [Abstract][Full Text] [Related]
15. Risk-adapted chemotherapy of germ cell tumors with carboplatin, etoposide and bleomycin for low-risk and cisplatin, etoposide and ifosfamide for high-risk patients. A single-center study.
Tscherry G; Jacky E; Jost LM; Stahel RA
Oncology; 2000 Aug; 59(2):110-7. PubMed ID: 10971168
[TBL] [Abstract][Full Text] [Related]
16. Gynecologic Oncology Group experience with ifosfamide.
Sutton GP; Blessing JA; Photopulos G; Berman ML; Homesley HD
Semin Oncol; 1990 Apr; 17(2 Suppl 4):6-10. PubMed ID: 2159188
[TBL] [Abstract][Full Text] [Related]
17. Tandem high dose chemotherapy with autologous bone marrow transplantation for initial relapse of testicular germ cell cancer.
Broun ER; Nichols CR; Gize G; Cornetta K; Hromas RA; Schacht B; Einhorn LH
Cancer; 1997 Apr; 79(8):1605-10. PubMed ID: 9118046
[TBL] [Abstract][Full Text] [Related]
18. A phase II study of ifosfamide, carboplatin and cisplatin in advanced and recurrent squamous cell carcinoma of the uterine cervix.
Filtenborg TA; Hansen HH; Aage Engelholm S; Rørth M
Ann Oncol; 1993 Jun; 4(6):485-8. PubMed ID: 8353091
[TBL] [Abstract][Full Text] [Related]
19. Lomustine (chloroethylnitrosourea [CCNU]), ifosfamide, bleomycin, vincristine, and cisplatin (CIBO-P) is an effective regimen for patients with poor prognostic refractory or multiple disease recurrent aggressive non-Hodgkin lymphoma.
Musolino A; Perrone MA; Michiara M; Delnevo D; Franciosi V; Di Blasio B; Ceci G; Camisa R; Ardizzoni A; Cocconi G
Cancer; 2005 May; 103(10):2109-17. PubMed ID: 15803492
[TBL] [Abstract][Full Text] [Related]
20. Treatment of gynecological malignancies with a combination of cisplatin, adriamycin and ifosfamide.
Nishida T; Nagasue N; Yakushiji M
Cancer Chemother Pharmacol; 1990; 26 Suppl():S39-42. PubMed ID: 2347048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
